$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

$fsi Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224012435 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$9.225M	$9.425M	$38.32M
YoY Change	-6.32%	-22.79%	-16.4%
Cost Of Revenue	$6.405M	$6.684M	$27.99M
YoY Change	-5.29%	-27.3%	-12.46%
Gross Profit	$2.820M	$2.741M	$10.34M
YoY Change	-8.58%	-9.02%	-25.46%
Gross Profit Margin	30.57%	29.08%	26.97%
Selling, General & Admin	$1.930M	$1.439M	$6.718M
YoY Change	10.65%	-10.33%	4.92%
% of Gross Profit	68.41%	52.49%	64.99%
Research & Development	$126.7K	$68.08K	$158.3K
YoY Change	489.03%	89.48%	59.41%
% of Gross Profit	4.49%	2.48%	1.53%
Depreciation & Amortization	$382.7K	$471.1K	$1.686M
YoY Change	26.37%	1.2%	52.78%
% of Gross Profit	13.57%	17.19%	16.31%
Operating Expenses	$2.230M	$1.507M	$6.877M
YoY Change	17.19%	-8.15%	0.85%
Operating Profit	$590.6K	$1.234M	$3.461M
YoY Change	-50.05%	-10.05%	-50.91%
Interest Expense	$175.3K	$54.98K	$157.8K
YoY Change	29.95%	-0.79%	-46.12%
% of Operating Profit	29.68%	4.45%	4.56%
Other Income/Expense, Net
YoY Change
Pretax Income	$780.4K	$1.294M	$3.623M
YoY Change	-38.27%	-9.37%	-53.9%
Income Tax	$264.2K	-$1.007M	-$132.7K
% Of Pretax Income	33.85%	-77.79%	-3.66%
Net Earnings	$457.2K	$1.800M	$2.776M
YoY Change	-48.3%	-33.78%	-60.47%
Net Earnings / Revenue	4.96%	19.1%	7.24%
Basic Earnings Per Share	$0.04		$0.22
Diluted Earnings Per Share	$0.04	$0.14	$0.22
COMMON SHARES
Basic Shares Outstanding	12.45M shares	12.44M shares	12.43M shares
Diluted Shares Outstanding	12.45M shares		12.49M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.303M	$5.018M	$5.018M
YoY Change	-4.11%	-17.95%	-17.95%
Cash & Equivalents	$8.327M	$5.018M	$5.018M
Short-Term Investments
Other Short-Term Assets	$3.765M	$4.231M	$4.231M
YoY Change	182.72%	318.8%	318.8%
Inventory	$10.46M	$11.13M	$11.13M
Prepaid Expenses	$741.5K	$1.541M
Receivables	$12.99M	$9.843M	$9.843M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$32.52M	$30.23M	$30.23M
YoY Change	1.39%	-2.48%	-2.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.27M	$13.29M	$13.29M
YoY Change	37.92%	36.85%	34.53%
Goodwill	$2.534M	$2.534M
YoY Change	0.0%	0.0%
Intangibles	$2.240M	$2.280M
YoY Change	-6.67%	-6.56%
Long-Term Investments	$5.889M	$6.858M	$6.858M
YoY Change	6.52%	25.63%	25.44%
Other Assets	$284.8K	$284.8K	$284.8K
YoY Change	3.83%	3.83%	3.83%
Total Long-Term Assets	$25.06M	$25.24M	$25.24M
YoY Change	20.1%	22.59%	22.59%
TOTAL ASSETS
Total Short-Term Assets	$32.52M	$30.23M	$30.23M
Total Long-Term Assets	$25.06M	$25.24M	$25.24M
Total Assets	$57.58M	$55.47M	$55.47M
YoY Change	8.76%	7.53%	7.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.398M	$1.985M	$1.985M
YoY Change	-5.11%	127.09%	127.1%
Accrued Expenses	$699.0K	$343.7K	$343.7K
YoY Change	285.28%	-64.2%	-66.24%
Deferred Revenue
YoY Change
Short-Term Debt	$3.260M	$1.810M	$1.810M
YoY Change	-11.02%	-35.77%	-35.77%
Long-Term Debt Due	$1.665M	$1.282M	$1.282M
YoY Change	131.44%	78.6%	78.6%
Total Short-Term Liabilities	$11.90M	$10.05M	$10.05M
YoY Change	9.71%	-2.41%	-2.41%
LONG-TERM LIABILITIES
Long-Term Debt	$6.321M	$6.833M	$6.833M
YoY Change	20.25%	25.69%	25.69%
Other Long-Term Liabilities	$0.00	$55.77K	$55.77K
YoY Change	-100.0%	-48.9%	-48.9%
Total Long-Term Liabilities	$6.321M	$6.889M	$6.889M
YoY Change	20.25%	26.72%	24.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.90M	$10.05M	$10.05M
Total Long-Term Liabilities	$6.321M	$6.889M	$6.889M
Total Liabilities	$18.48M	$20.27M	$20.27M
YoY Change	10.67%	23.98%	6.94%
SHAREHOLDERS EQUITY
Retained Earnings	$18.51M	$18.05M
YoY Change	10.26%	13.51%
Common Stock	$12.45K	$12.44K
YoY Change	0.12%	0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$35.97M	$35.20M	$35.20M
YoY Change
Total Liabilities & Shareholders Equity	$57.58M	$55.47M	$55.47M
YoY Change	8.76%	7.53%	7.53%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$457.2K	$1.800M	$2.776M
YoY Change	-48.3%	-33.78%	-60.47%
Depreciation, Depletion And Amortization	$382.7K	$471.1K	$1.686M
YoY Change	26.37%	1.2%	52.78%
Cash From Operating Activities	-$532.3K	-$3.138M	$6.990M
YoY Change	133.21%	-246.95%	373.29%
INVESTING ACTIVITIES
Capital Expenditures	$478.1K	$276.9K	$4.991M
YoY Change	124.41%	-79.25%	151.89%
Acquisitions
YoY Change
Other Investing Activities	$305.2K	-$510.3K	-$679.3K
YoY Change	-189.05%	-426.59%	189.88%
Cash From Investing Activities	-$172.9K	-$787.2K	-$5.670M
YoY Change	-68.89%	-33.17%	155.91%
FINANCING ACTIVITIES
Cash Dividend Paid			$626.8K
YoY Change
Common Stock Issuance & Retirement, Net			$13.60K
YoY Change			-90.33%
Debt Paid & Issued, Net	$185.9K		$725.8K
YoY Change	4.66%		-68.34%
Cash From Financing Activities	$1.297M	1.869M	-438.0K
YoY Change	94.61%	23.05%	-151.63%
NET CHANGE
Cash From Operating Activities	-$532.3K	-3.138M	6.990M
Cash From Investing Activities	-$172.9K	-787.2K	-5.670M
Cash From Financing Activities	$1.297M	1.869M	-438.0K
Net Change In Cash	$618.9K	-2.057M	882.1K
YoY Change	-317.21%	-183.06%	1009.19%
FREE CASH FLOW
Cash From Operating Activities	-$532.3K	-$3.138M	$6.990M
Capital Expenditures	$478.1K	$276.9K	$4.991M
Free Cash Flow	-$1.010M	-$3.415M	$1.999M
YoY Change	128.96%	-526.15%	-496.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001069394
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A0
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023	FSI	Gain On Previously Held Equity Interest GainOnPreviouslyHeldEquityInterest		usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	FSI	Gain On Acquisition Of Subsidiary GainOnAcquisitionOfSubsidiary		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022	FSI	Proceeds From Redemption Of Investments ProceedsFromRedemptionOfInvestments		usd
CY2022	FSI	Proceeds From Noncontrolling Interest Of Mendota ProceedsFromNoncontrollingInterestOfMendota		usd
CY2022	FSI	Payments To Acquire Long Term Deposits PaymentsToAcquireLongTermDeposits		usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q4	us-gaap	Investments Investments		usd
CY2023	FSI	Proceeds From Loan Acquired From Acquisition ProceedsFromLoanAcquiredFromAcquisition		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-31540
CY2023	dei	Entity Registrant Name EntityRegistrantName	FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	71-1630889
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	6001 54 Ave.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Taber
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AB
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	T1G 1X4
CY2023	dei	City Area Code CityAreaCode	(403)
CY2023	dei	Local Phone Number LocalPhoneNumber	223-2995
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023	dei	Trading Symbol TradingSymbol	FSI
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	19343103	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12450532	shares
CY2023	dei	Auditor Name AuditorName	Smythe LLP
CY2023	dei	Auditor Firm AuditorFirmId	995
CY2023	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2023Q4	us-gaap	Cash Cash	5017583	usd
CY2022Q4	us-gaap	Cash Cash	6115099	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2690241	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	700000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9843056	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9449857	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11134889	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14419430	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1540923	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	310297	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	30226692	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30994683	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13171787	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9709288	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	115293	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2280000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2440000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	824254	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	6033960	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5458895	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	284794	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	274289	usd
CY2023Q4	us-gaap	Assets Assets	55471055	usd
CY2022Q4	us-gaap	Assets Assets	51587192	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1984592	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	873904	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	284131	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	959856	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	148292	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	387763	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4485213	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4486350	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1810479	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2818591	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	59520	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	58080	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1281632	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	717612	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10053859	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10302156	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	55773	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	109142	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	260047	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	500459	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6833304	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5436465	usd
CY2023Q4	us-gaap	Liabilities Liabilities	17202983	usd
CY2022Q4	us-gaap	Liabilities Liabilities	16348222	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12435532	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12435532	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12426260	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12426260	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12436	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12426	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17932015	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17523345	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-795146	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-805799	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18053051	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15903964	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35202356	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	32633936	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	3065716	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2605034	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38268072	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35238970	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55471055	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51587192	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38324806	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45840469	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27987451	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	31971596	usd
CY2023	us-gaap	Gross Profit GrossProfit	10337355	usd
CY2022	us-gaap	Gross Profit GrossProfit	13868873	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	2659654	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	2537783	usd
CY2023	us-gaap	Officers Compensation OfficersCompensation	1205007	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	1032394	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	861501	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	683272	usd
CY2023	us-gaap	Other General Expense OtherGeneralExpense	508376	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	350126	usd
CY2023	us-gaap	Interest Expense InterestExpense	498666	usd
CY2022	us-gaap	Interest Expense InterestExpense	292949	usd
CY2023	FSI	Consulting Consulting	324327	usd
CY2022	FSI	Consulting Consulting	312171	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	660821	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	194308	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	182609	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	158246	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	99275	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	97806	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	149446	usd
CY2023	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	55093	usd
CY2022	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	42098	usd
CY2022	FSI	Commissions Commissions	30732	usd
CY2023	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	26854	usd
CY2022	us-gaap	Utilities Operating Expense UtilitiesOperatingExpense	29517	usd
CY2023	FSI	Shipping Cost ShippingCost	24060	usd
CY2022	FSI	Shipping Cost ShippingCost	23469	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	37632	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-23091	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	17869	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	7337568	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6818496	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2999787	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	7050377	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4589	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	505065	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	341424	usd
CY2022	FSI	Gain On Previously Held Equity Interest GainOnPreviouslyHeldEquityInterest	335051	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	113809	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	132233	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3623250	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7859085	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-250917	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-71295	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	118182	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	217151	usd
CY2023	us-gaap	Profit Loss ProfitLoss	3755985	usd
CY2022	us-gaap	Profit Loss ProfitLoss	7713229	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	980121	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	691625	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2775864	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7021604	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12434886	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12379316	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12489467	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12466415	shares
CY2023	us-gaap	Profit Loss ProfitLoss	3755985	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10653	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30069	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3766638	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	7683160	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	980121	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	691625	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2786517	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6991535	usd
CY2023	us-gaap	Profit Loss ProfitLoss	3755985	usd
CY2022	us-gaap	Profit Loss ProfitLoss	7713229	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	395080	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	399148	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1686319	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1277431	usd
CY2023	FSI	Lease Right Of Use Financing LeaseRightOfUseFinancing	6151	usd
CY2022	FSI	Lease Right Of Use Financing LeaseRightOfUseFinancing	8566	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	51929	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	50045	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	505065	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	341424	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4589	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	17869	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-250917	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-71295	usd
CY2022	FSI	Gain On Acquisition Of Subsidiary GainOnAcquisitionOfSubsidiary	335051	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	393199	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2338397	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3284541	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4124022	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1230626	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-131864	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	434964	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-700191	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1137	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-249628	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-239471	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	38759	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6989965	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1476903	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	470000	usd
CY2023	FSI	Proceeds From Redemption Of Investments ProceedsFromRedemptionOfInvestments	200000	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	201034	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	265001	usd
CY2023	FSI	Proceeds From Noncontrolling Interest Of Mendota ProceedsFromNoncontrollingInterestOfMendota	200000	usd
CY2023	FSI	Payments To Acquire Long Term Deposits PaymentsToAcquireLongTermDeposits	815714	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	5411	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4990675	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1981307	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	499329	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5669944	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2215635	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1008112	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	517772	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	725823	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2292819	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2686682	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3230798	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	58080	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	58611	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	626777	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	719439	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	689434	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13600	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	140620	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-437949	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	848326	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10653	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-30069	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	892725	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	79525	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6815099	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6735574	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7707824	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6815099	usd
CY2023Q4	us-gaap	Cash Cash	5017583	usd
CY2022Q4	us-gaap	Cash Cash	6115099	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	2690241	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	700000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7707824	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6815099	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	119319	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	158966	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	498666	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	292949	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27705476	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-30069	usd
CY2022	us-gaap	Profit Loss ProfitLoss	7713229	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	140620	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	689434	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	399148	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35238970	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35238970	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	10653	usd
CY2023	us-gaap	Dividends Dividends	626777	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	200000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	3755985	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13600	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	719439	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	395080	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38268072	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38268072	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zPrJV4zzeON3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <i><span id="xdx_86D_zMAJ53TEfp74">Use of Estimates</span></i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and would impact the results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible assets, valuation of assets acquired at fair value, asset impairment analysis, share-based payments, valuation allowances for deferred income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts receivable, recoverability of investments, discount rates for right of use assets and the costing and recoverable value of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zyN75VQ7gh4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <i><span id="xdx_867_zLc9Btx4n2I1">Risk Management</span>.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure is minimized by dealing with only credit worthy counterparties.. Revenue for the Company’s three primary customers totaled $<span id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zlK2hjD0gND1" title="Sales">20,482,798</span> (<span id="xdx_903_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zaaB9xAxdoF8" title="Accounts receivable, after allowance for credit loss">53</span>%) for the year ended December 31, 2023 (2022 - $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zf9GtvZnSwgj" title="Sales">27,775,616</span> or <span id="xdx_903_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z7vFR6y5thx3" title="Accounts receivable, after allowance for credit loss">61</span>%). Accounts receivable for the Company’s three primary customers totaled $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z7xqzWiIU5j6" title="Sale">6,561,164</span> (<span id="xdx_90E_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zz5uZIR3fuG2" title="Accounts receivable, after allowance for credit loss, percentage">67</span>%) at December 31, 2023 (2022 - $<span id="xdx_902_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zOqkKntT3LYd" title="Sale">6,124,424</span> or <span id="xdx_90B_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreePrimaryCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_znlM6IW2Ryxa" title="Accounts receivable, after allowance for credit loss, percentage">65</span>%).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions. The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced any losses in such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to foreign risk to the extent that market value rate fluctuations materially differ for financial assets and liabilities denominated in foreign currencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to foreign exchange risks, the Company is closely monitoring the fluctuations in the foreign currency exchange rates and the impact on the value of cash, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged its exposure to currency fluctuations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt subject to fixed long-term interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to manage its exposure to interest rate risk, the Company is closely monitoring fluctuations in market interest risks and will refinance its long-term debt where possible to obtain more favourable rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.055	pure
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	217267	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	50045	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	167222	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	51929	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	115293	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	217267	usd
CY2022	FSI	Lease Interest Expense LeaseInterestExpense	8566	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	58611	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	167222	usd
CY2023	FSI	Lease Interest Expense LeaseInterestExpense	6151	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	58080	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	115293	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	59520	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	55773	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	115293	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59520	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	61020	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	120540	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5247	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	115293	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	10133249	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	9739150	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	290193	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	289293	usd
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	9843056	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	9449857	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2682158	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3806646	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	8452731	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	10612784	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11134889	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14419430	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23365705	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10193918	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13171787	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18399675	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8690387	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9709288	usd
CY2023	us-gaap	Depreciation Depreciation	1526319	usd
CY2022	us-gaap	Depreciation Depreciation	1103732	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4589	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	200444	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	200444	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	195725	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	195725	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2534275	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	770000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	160000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	160000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	824254	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8540	usd
CY2022	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	506659	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	7330	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	3750000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	150000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	174582	usd
CY2022Q4	FSI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt	-2849500	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	883248	usd
CY2022Q4	FSI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Less Purchase Price BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLessPurchasePrice	376589	usd
CY2022	FSI	Investment Eliminated Upon Consolidation InvestmentEliminatedUponConsolidation	-41538	usd
CY2022	FSI	Gain On Acquisition Of Subsidiary GainOnAcquisitionOfSubsidiary	335051	usd
CY2021	FSI	Debt Instrument Maturity Month Year DebtInstrumentMaturityMonthYear	2023-12
CY2023Q4	us-gaap	Investments Investments	200000	usd
CY2022Q4	us-gaap	Investments Investments	200000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	16043468	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	18103070	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	4668177	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	4204311	usd
CY2023	FSI	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet	1010128	usd
CY2022	FSI	Realized Investment Gains Losses Net RealizedInvestmentGainsLossesNet	615055	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2366598	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2366598	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	2686682	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3230798	usd
CY2022	FSI	Proceeds From Loan Acquired From Acquisition ProceedsFromLoanAcquiredFromAcquisition	2849500	usd
CY2023	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	725823	usd
CY2022	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	2292819	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	8114936	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	8114936	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	6154077	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1281632	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	717612	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6833304	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5436465	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	753683	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1017059	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	340952	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	460098	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	151236	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	216082	usd
CY2023	FSI	Current Tax CurrentTax	1245871	usd
CY2022	FSI	Current Tax CurrentTax	1693239	usd
CY2023	FSI	Income Tax Recovery IncomeTaxRecovery	1127689	usd
CY2022	FSI	Income Tax Recovery IncomeTaxRecovery	1476088	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	118182	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	217151	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-172763	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-49088	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-78154	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-22207	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-250917	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-71295	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132735	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145856	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3623250	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7859085	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3050	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3050	pure
CY2023	FSI	Expected Income Tax Recovery ExpectedIncomeTaxRecovery	1105091	usd
CY2022	FSI	Expected Income Tax Recovery ExpectedIncomeTaxRecovery	2397021	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	362554	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-243167	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1585427	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2004041	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-92379	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-226611	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	77426	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-222654	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132735	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145856	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	118182	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	217151	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-250917	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-71295	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132735	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	145856	usd
CY2023	FSI	Income Tax Recovery IncomeTaxRecovery	1127689	usd
CY2022	FSI	Income Tax Recovery IncomeTaxRecovery	1476088	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3718155	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2775864	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7021604	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12434886	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12379316	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12489467	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12466415	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	740000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1304000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	1	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	789500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	981000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.55
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	13486	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.32
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	71014	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.98
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1686000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.26
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	564000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.55
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8000	shares
CY2023	FSI	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Excercised Options Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExcercisedOptionsExercisePrice	1.70
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.70
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1114000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	754000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.93
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	375351	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2023	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1272	shares
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4070	usd
CY2023Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.05
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segments
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38324806	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45840469	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	18101355	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	14850786	usd
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
R39.htm	Edgar Link	pending
0001493152-24-012435-index-headers.html	Edgar Link	pending
0001493152-24-012435-index.html	Edgar Link	pending
0001493152-24-012435.txt	Edgar Link	pending
0001493152-24-012435-xbrl.zip	Edgar Link	pending
ex19.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
fsi-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
fsi-20231231_cal.xml	Edgar Link	unprocessable
fsi-20231231_def.xml	Edgar Link	unprocessable
fsi-20231231_lab.xml	Edgar Link	unprocessable
fsi-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

2024 Q1 Form 10-K Financial Statement

#000149315224012435 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi

2024 Q1 Form 10-K Financial Statement

#000149315224012435 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FSI
FLEXIBLE SOLUTIONS INTERNATIONAL INC Stock $fsi